-
Product Insights
NewLikelihood of Approval Analysis for Chronic Obstructive Pulmonary Disease (COPD)
Overview How likely is it that the drugs in Chronic Obstructive Pulmonary Disease (COPD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Obstructive Pulmonary Disease (COPD) Overview Chronic obstructive pulmonary...
-
Product Insights
NewLikelihood of Approval Analysis for Bacterial Pneumonia
Overview How likely is it that the drugs in Bacterial Pneumonia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bacterial Pneumonia Overview Bacterial pneumonia is a lung infection caused by bacteria...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Marrow Transplant Rejection
Overview How likely is it that the drugs in Bone Marrow Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Marrow Transplant Rejection Overview Bone marrow transplant rejection is...
-
Product Insights
NewLikelihood of Approval Analysis for Graft Versus Host Disease (GVHD)
Overview How likely is it that the drugs in Graft Versus Host Disease (GVHD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Graft Versus Host Disease (GVHD) Overview Graft-versus-host disease (GVHD)...
-
Product Insights
NewLikelihood of Approval Analysis for Grass Pollen Allergy
Overview How likely is it that the drugs in Grass Pollen Allergy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Grass Pollen Allergy Overview Grass pollen allergy is a reaction which...
-
Product Insights
NewLikelihood of Approval Analysis for Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Overview How likely is it that the drugs in Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hereditary Angioedema (HAE) (C1 Esterase Inhibitor...
-
Product Insights
NewLikelihood of Approval Analysis for Anemia in Chronic Kidney Disease (Renal Anemia)
Overview How likely is it that the drugs in Anemia in Chronic Kidney Disease (Renal Anemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia in Chronic Kidney Disease (Renal Anemia)...
-
Product Insights
NewLikelihood of Approval Analysis for Systemic Mastocytosis
Overview How likely is it that the drugs in Systemic Mastocytosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Mastocytosis Overview Systemic mastocytosis is a disorder where mast cells are...
-
Product Insights
NewLikelihood of Approval Analysis for Paroxysmal Nocturnal Hemoglobinuria
Overview How likely is it that the drugs in Paroxysmal Nocturnal Hemoglobinuria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paroxysmal Nocturnal Hemoglobinuria Overview Paroxysmal nocturnal hemoglobinuria is a rare disease...
-
Product Insights
NewLikelihood of Approval Analysis for Sickle Cell Disease With Vaso-Occlusive Crisis
Overview How likely is it that the drugs in Sickle Cell Disease With Vaso-Occlusive Crisis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sickle Cell Disease With Vaso-Occlusive Crisis Overview Vaso-occlusive...